Skip to main content
Caplight Logo









Seven and Eight Biopharmaceuticals Inc.

Seven and Eight Biopharmaceuticals Inc.

Private
Edison, New JerseyHealthcare & Life Scienceshttps://7and8biopharma.com

Company Overview

Seven and Eight Biopharmaceuticals Inc. is a biotechnology company that develops novel immuno-oncology therapies targeting toll-like receptors to treat cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

immuno-oncologyTLR7/8 agonistscancer immunotherapytoll-like receptorTLRdrug licensingsolid tumor treatmentsmall-molecule therapeuticsbiotech drug developmentclinical-stage biotechTLACtoll-like receptor ligand antibody conjugationcancer drug pipelinebiopharma partneringcancer vaccine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Seven and Eight Biopharmaceuticals Inc. Comparables

Compare Seven and Eight Biopharmaceuticals Inc. with similar companies based on industry and business-model similarity.

Seven and Eight Biopharmaceuticals Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eikon Therapeutics
82%
Inimmune
81%
Primmune Therapeutics
80%

Seven and Eight Biopharmaceuticals Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Seven and Eight Biopharmaceuticals Inc. Filings

Explore SEC and related filing metadata, where available.

Seven and Eight Biopharmaceuticals Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Seven and Eight Biopharmaceuticals Inc.'s valuation, stock price, and market status.

Is Seven and Eight Biopharmaceuticals Inc. a public or private company?

Seven and Eight Biopharmaceuticals Inc. is a private company.

What is the current stock price of Seven and Eight Biopharmaceuticals Inc.?

Seven and Eight Biopharmaceuticals Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Seven and Eight Biopharmaceuticals Inc. worth (valuation)?

Valuation information for Seven and Eight Biopharmaceuticals Inc. is not publicly available.

Can I buy Seven and Eight Biopharmaceuticals Inc. stock?

Seven and Eight Biopharmaceuticals Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Seven and Eight Biopharmaceuticals Inc.'s last funding round?

Funding round information for Seven and Eight Biopharmaceuticals Inc. is not publicly available.

Who are the main investors in Seven and Eight Biopharmaceuticals Inc.?

Investor information for Seven and Eight Biopharmaceuticals Inc. is not publicly disclosed.

Will Seven and Eight Biopharmaceuticals Inc. IPO soon?

No public IPO plans have been announced for Seven and Eight Biopharmaceuticals Inc..

How can I track Seven and Eight Biopharmaceuticals Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Seven and Eight Biopharmaceuticals Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEdison, New Jersey
Employee Range2
Year Founded2012
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?